Adjuvant Dual Anti-HER2 Therapy in Patients With Small, Node-negative, HER2-positive Breast Cancer
Clinical trial NCT04158856 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT04158856
- Sponsor
- xuexin he
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2023-05-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.